Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.

Einsiedler M, Sandgren S, Schaedelin S, Ning K, Maleska Maceski A, Oechtering J, Cordano C, Melie-Garcia L, Gelfand JM, Cagol A, Henry RG, Finkener S, Lalive PH, Müller S, Pot C, Mathias A, Du Pasquier R, Hoepner R, Chan A, Disanto G, Zecca C, D'Souza M, Hemkens LG, Yaldizli Ö, Fischer-Barnicol B, Derfuss T, Roth P, Herwerth M, Gobbi C, Brassat D, Tackenberg B, Pedotti R, Wiendl H, Berger K, Hermesdorf M, Arrambide G, Piehl F, Zetterberg H, Cree BAC, Sormani MP, Kappos L, Hauser SL, Khalil M, Granziera C, Green AJ, Leppert D, Benkert P, Abdelhak A, Kuhle J, Expression, Proteomics, Imaging, Clinical (EPIC) study and the Swiss MS Cohort (SMSC) investigators, Hofer L, Hughes M, Genc N, Zadic A, Vilchez Gomez JF, Galbusera R, Galli E, Müller J, Uginet M, Kana V, Raposo C, Oksenberg J, Conen D

Open source

DOI: 10.1001/jamaneurol.2026.2500
Published: 2026 Sep 1
Container: JAMA neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamaneurol.2026.2500,
  title = {Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.},
  author = {Einsiedler M and Sandgren S and Schaedelin S and Ning K and Maleska Maceski A and Oechtering J and Cordano C and Melie-Garcia L and Gelfand JM and Cagol A and Henry RG and Finkener S and Lalive PH and Müller S and Pot C and Mathias A and Du Pasquier R and Hoepner R and Chan A and Disanto G and Zecca C and D'Souza M and Hemkens LG and Yaldizli Ö and Fischer-Barnicol B and Derfuss T and Roth P and Herwerth M and Gobbi C and Brassat D and Tackenberg B and Pedotti R and Wiendl H and Berger K and Hermesdorf M and Arrambide G and Piehl F and Zetterberg H and Cree BAC and Sormani MP and Kappos L and Hauser SL and Khalil M and Granziera C and Green AJ and Leppert D and Benkert P and Abdelhak A and Kuhle J and Expression, Proteomics, Imaging, Clinical (EPIC) study and the Swiss MS Cohort (SMSC) investigators and Hofer L and Hughes M and Genc N and Zadic A and Vilchez Gomez JF and Galbusera R and Galli E and Müller J and Uginet M and Kana V and Raposo C and Oksenberg J and Conen D},
  year = {2026},
  journal = {JAMA neurology},
  doi = {10.1001/jamaneurol.2026.2500},
  url = {https://doi.org/10.1001/jamaneurol.2026.2500}
}

RIS

TY  - JOUR
TI  - Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.
AU  - Einsiedler M
AU  - Sandgren S
AU  - Schaedelin S
AU  - Ning K
AU  - Maleska Maceski A
AU  - Oechtering J
AU  - Cordano C
AU  - Melie-Garcia L
AU  - Gelfand JM
AU  - Cagol A
AU  - Henry RG
AU  - Finkener S
AU  - Lalive PH
AU  - Müller S
AU  - Pot C
AU  - Mathias A
AU  - Du Pasquier R
AU  - Hoepner R
AU  - Chan A
AU  - Disanto G
AU  - Zecca C
AU  - D'Souza M
AU  - Hemkens LG
AU  - Yaldizli Ö
AU  - Fischer-Barnicol B
AU  - Derfuss T
AU  - Roth P
AU  - Herwerth M
AU  - Gobbi C
AU  - Brassat D
AU  - Tackenberg B
AU  - Pedotti R
AU  - Wiendl H
AU  - Berger K
AU  - Hermesdorf M
AU  - Arrambide G
AU  - Piehl F
AU  - Zetterberg H
AU  - Cree BAC
AU  - Sormani MP
AU  - Kappos L
AU  - Hauser SL
AU  - Khalil M
AU  - Granziera C
AU  - Green AJ
AU  - Leppert D
AU  - Benkert P
AU  - Abdelhak A
AU  - Kuhle J
AU  - Expression, Proteomics, Imaging, Clinical (EPIC) study and the Swiss MS Cohort (SMSC) investigators
AU  - Hofer L
AU  - Hughes M
AU  - Genc N
AU  - Zadic A
AU  - Vilchez Gomez JF
AU  - Galbusera R
AU  - Galli E
AU  - Müller J
AU  - Uginet M
AU  - Kana V
AU  - Raposo C
AU  - Oksenberg J
AU  - Conen D
PY  - 2026
JO  - JAMA neurology
DO  - 10.1001/jamaneurol.2026.2500
UR  - https://doi.org/10.1001/jamaneurol.2026.2500
ER  -

APA

M, E., S, S., S, S., K, N., A, M. M., J, O., C, C., L, M., JM, G., A, C., RG, H., S, F., PH, L., S, M., C, P., A, M., R, D. P., R, H., A, C., G, D., C, Z., M, D., LG, H., Ö, Y., B, F., T, D., P, R., M, H., C, G., D, B., B, T., R, P., H, W., K, B., M, H., G, A., F, P., H, Z., BAC, C., MP, S., L, K., SL, H., M, K., C, G., AJ, G., D, L., P, B., A, A., J, K., investigators, E. P. I. C. (. S. A. T. S. M. C. (., L, H., M, H., N, G., A, Z., JF, V. G., R, G., E, G., J, M., M, U., V, K., C, R., J, O., & D, C. (2026). Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.. JAMA neurology. https://doi.org/10.1001/jamaneurol.2026.2500

Source records

pubmed · retrieved 2026-09-25T05:06:29.246Z